|
1.
|
|
7 p, 793.0 KB |
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation : A retrospective analysis of the EBMT chronic malignancies working party
/
Scheid, C. (University of Cologne) ;
De Wreede, L. (DKMS. German Bone Marrow Donor Center) ;
Van Biezen, A. (Leiden University Medical Center) ;
Koenecke, C. (Hannover Medical School) ;
Göhring, G. (Hannover Medical School) ;
Volin, L. (HUCH Comprehensive Cancer Center) ;
Maertens, J. (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Finke, J. (University of Freiburg) ;
Passweg, J. (University Hospital) ;
Beelen, D. (University Hospital) ;
Cornelissen, J. J. (University Medical Center Rotterdam) ;
Itälä-Remes, M. (Turku University Hospital (Finlàndia)) ;
Chevallier, P. (CHU Nantes) ;
Russell, N. (Nottingham University) ;
Petersen, E. (University Medical Centre) ;
Milpied, N. (Hôpital Haut-leveque) ;
Richard Espiga, C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Peniket, A. (Churchill Hospital) ;
Sierra Llopart, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Mufti, G. (GKT School of Medicine) ;
Crawley, C. (Addenbrookes Hospital (Cambridge, Regne Unit)) ;
Veelken, J.H. (Leiden University Hospital) ;
Ljungman, P. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Cahn, Jean-Yves (Hopital A. Michallon) ;
Alessandrino, E.P. (Fondazione IRCCS Policlinico San Matteo) ;
De Witte, T. (Radboud University-Nijmegen Medical Centre) ;
Robin, M. (Hopital St. Louis) ;
Kröger, N. (University Hospital Eppendorf) ;
Universitat Autònoma de Barcelona
The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate the use of the IPSS-R assessed before transplant rather than at diagnosis we performed a retrospective analysis of the EBMT database. [...]
2017 -  10.1038/bmt.2017.171
Bone marrow transplantation, Vol. 52 Núm. 11 (january 2017) , p. 1519-1525
|
|
|
2.
|
|
6 p, 657.1 KB |
Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation : A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study
/
Paviglianiti, Annalisa (Centre Scientifique de Monaco) ;
Tozatto Maio, Karina (Centre Scientifique de Monaco) ;
Rocha, Vanderson (Hospital Sao Paulo) ;
Gehlkopf, Eve (CHU Lapeyronie) ;
Milpied, Noel (CHU Bordeaux) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ;
Blaise, Didier (Institute Paoli Calmettes) ;
Gac, Anne-Claire (Institut d'Hématologie de Basse-Normandie) ;
Leblond, Véronique (Hopital la Pitié-Salpêtrière) ;
Cahn, Jean-Yves (CHU Grenoble Alpes) ;
Abecasis, Manuel (Institute Portugues Oncologia) ;
Zuckerman, Tsila (Rambam Medical Center) ;
Schouten, Harry (University Hospital Maastricht) ;
Gurman, Gunhan (Ankara University) ;
Rubio, Marie Thérèse (Hôpitaux des Brabois) ;
Beguin, Yves (CHU of Liège and University of Liege) ;
Corral, Lucia Lopez (Centro de Investigacion del Cancer-IBMCC) ;
Nagler, Amon (Chaim Sheba Medical Center (Israel)) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Trust) ;
Koc, Yener (Stem Cell Transplant Unit Medical Park Hospitals) ;
Mordini, Nicola (Az. Ospedaliera S. Croce e Carle) ;
Bonifazi, Francesca ("Seragnoli" University Hospital S. Orsola-Malpighi) ;
Volt, Fernanda (Centre Scientifique de Monaco) ;
Kenzey, Chantal (Centre Scientifique de Monaco) ;
Robinson, Stephen Paul (EBMT Lymphoma Working Party) ;
Montoto, Silvia (EBMT Lymphoma Working Party) ;
Gluckman, Eliane (Centre Scientifique de Monaco) ;
Ruggeri, Annalisa (Bambin Gesù) ;
Universitat Autònoma de Barcelona
Allogeneic stem cell transplantation is an alternative for patients with relapsed or refractory Hodgkin lymphoma (HL), but only limited data on unrelated umbilical cord blood transplantation (UCBT) are available. [...]
2018 - 10.1016/j.bbmt.2018.07.019
Biology of blood and marrow transplantation, Vol. 24 Núm. 11 (november 2018) , p. 2265-2270
|
|
|
3.
|
|
11 p, 340.8 KB |
Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
/
Rafii, Hanadi (Centre Scientifique de Monaco) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milan, Itàlia)) ;
Kenzey, Chantal (Centre Scientifique de Monaco) ;
Sanz, Jaime (Hospital Universitari i Politècnic La Fe (València)) ;
Peffault De La Tour, Régis (Assistance Publique-Hôpitaux de Paris) ;
Esquirol, Albert (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Michel, Gérard (Hopital pédiatrique de la Timone (Marseille, França)) ;
Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ;
Rubio, Marie-Thérèse (CHRU Nancy (Nancy, França)) ;
Cornelissen, Jan J. (Erasmus MC-Daniel den Hoed Cancer Centre) ;
Michallet, Mauricette (Centre Leon Berard) ;
Volt, Fernanda (Monacord, Centre Scientifique de Monaco) ;
Rivera-Franco, Monica M. (Centre Scientifique de Monaco) ;
Scigliuolo, Graziana Maria (Centre Scientifique de Monaco) ;
Cappelli, Barbara (Centre Scientifique de Monaco) ;
Rocha, Vanderson (São Paulo Medical School) ;
Gluckman, Eliane (Centre Scientifique de Monaco) ;
Universitat Autònoma de Barcelona
Subsequent neoplasms (SNs) compromise long-term survivors after hematopoietic cell transplantation. We performed a retrospective analysis of SNs in 10 358 recipients of umbilical cord blood transplantation (UCBT) from 1988 to 2018. [...]
2022 - 10.1182/bloodadvances.2022007941
Blood advances, Vol. 7 (november 2022) , p. 1976-1986
|
|
|
4.
|
|
11 p, 1.2 MB |
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
/
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
Bermúdez, Arancha (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ;
Logan, Aaron C. (Division of Hematology and Blood and Marrow Transplantation. Department of Medicine. University of California) ;
Kharfan-Dabaja, Mohamed A. (Department of Blood and Marrow Transplantation. H. Lee Moffitt Cancer Center and Research Institute and University of South Florida) ;
Chevallier, Patrice (Service d'Hématologie Clinique. CHU de Nantes. 44093. Nantes. France and CRCINA / INSERM UMR1232 / CNRS ERL6001 IRS UN - 8) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Wulf, Gerald (Department of Hematology and Medical Oncology. University Medical Center Göttingen) ;
Selleslag, Dominik (Department of Hematology. AZ Sint-Jan Brugge-Oostende) ;
Kakihana, Kazuhiko (Hematology Division. Tokyo Metropolitan Komagome Hospital) ;
Langston, Amelia (Winship Cancer Institute. Emory University) ;
Lee, Dong-Gun. (Division of Infectious Diseases. Department of Internal Medicine. Catholic Hematology Hospital and Seoul St. Mary's Hospital. College of Medicine. The Catholic University of Korea) ;
Solano, Carlos (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ;
Okamoto, Shinichiro (Division of Hematology. Department of Medicine. Kelo University School of Medicine) ;
Smith, Larry R. (Vical) ;
Boeckh, Michael (Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center and University of Washington) ;
Wingard, John Reid (Division of Hematology & Oncology. Department of Medicine. University of Florida) ;
Cywin, Beth (Astellas Pharma Global Development) ;
Fredericks, Christine (Astellas Pharma Global Development) ;
Lademacher, Christopher (Astellas Pharma Global Development) ;
Wang, Xuegong (Astellas Pharma Global Development) ;
Young, James (Astellas Pharma Global Development) ;
Maertens, Johan (K.U. Leuven and Department of Hematology)
Background: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ASP0113, a DNA-based vaccine, contains two plasmids encoding human CMV glycoprotein B and phosphoprotein 65 (pp65). [...]
2021 - 10.1016/j.eclinm.2021.100787
EClinicalMedicine, Vol. 33 (march 2021) , p. 100787
|
|
|
5.
|
|
4 p, 870.5 KB |
KMT2A-CBL rearrangements in acute leukemias : clinical characteristics and genetic breakpoints
/
Bataller, Alex (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Guijarro, Francesca (Universitat de Barcelona) ;
Caye-Eude, Aurélie (Department of Genetics and Molecular Genetics. AP-HP. Robert Debre Hospital) ;
Strullu, Marion (Department of Pediatric Hematology. AP-HP. Robert Debre Hospital) ;
Sterin, Arthur (Department of Pediatric Hematology. Immunology and Oncology. APHM. La Timone Children Hospital) ;
Molina, Oscar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Chevallier, Patrice (CHU Hotel-Dieu) ;
Zaliova, Marketa (Charles University Prague) ;
Zuna, Jan (Charles University Prague) ;
Mozas, Pablo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Magnano, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Grardel, Nathalie (University Hospital Claude Huriez) ;
Cornillet-Lefebvre, Pascale (Hôpital Robert Debre) ;
Fu, Jen-Fen (Chang Gung Memorial Hospital-Linkou) ;
Shih, Lee-Yung (Chang Gung Memorial Hospital) ;
Boneva, Temenuzhka (United Kingdom and UCL Cancer Institute) ;
Nacheva, Elisabeth (United Kingdom and UCL Cancer Institute) ;
Bea, Sílvia (Centro de Investigación Biomédica en Red de Cáncer) ;
López-Guerra, Mónica (Centro de Investigación Biomédica en Red de Cáncer) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Esteve Reyner, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Larghero, Patrizia (Goethe University Main) ;
Meyer, Claus (Goethe University Main) ;
Marschalek, Rolf (Goethe University Main)
2021 - 10.1182/bloodadvances.2021005736
Blood advances, Vol. 5 Núm. 24 (28 2021) , p. 5617-5620
|
|
|
6.
|
|
8 p, 732.8 KB |
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
/
Gagelmann, N. (University Medical Center Hamburg-Eppendorf) ;
Eikema, D. J. (EBMT Statistics) ;
Stelljes, M. (University of Münster) ;
Beelen, D. (University Hospital Essen (Alemanya)) ;
de Wreede, Liesbeth C (EBMT Statistics) ;
Mufti, G. (GKT School of Medicine) ;
Knelange, N. S. (EBMT Data Office) ;
Niederwieser, D. (University Hospital Leipzig) ;
Friis, L. S. (University of Copenhagen) ;
Ehninger, Gerhard (Universitätsklinikum Dresden) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Yakoub-Agha, Ibrahim (Université Lille2) ;
Meijer, E. (Amsterdam UMC. University Medical Center) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Kanz, L. (Universität Tübingen) ;
Lopez-Corral, L. (Hospital Clínico Universitario (Salamanca)) ;
Brecht, A. (Deutsche Klinik für Diagnostik) ;
Craddock, Charles (Centre for Clinical Haematology) ;
Finke, J. (University of Freiburg) ;
Cornelissen, J. J. (Erasmus MC Cancer Institute. Erasmus University Medical Center) ;
Bernasconi, P. (Fondazione IRCCS Policlinico San Matteo) ;
Chevallier, Patrice (CHU Nantes) ;
Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robin, M. (Hopital St. Louis) ;
Kroeger, Nicolaus (University Medical Center Hamburg-Eppendorf) ;
Universitat Autònoma de Barcelona
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation registry. [...]
2019 - 10.3324/haematol.2018.200808
Haematologica, Vol. 104 Núm. 5 (30 2019) , p. 929-936
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
